secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accustem Sciences Inc. (ACUT)
CIK:        0001850767
Form:       8-K
Filed at:   2022-11-16T23:59:59+00:00
Accession:  0001493152-22-032628
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AccuStem Sciences appoints Sean McDonald as independent director; board now five members
--------------------------------------------------------------------------------

- Sean McDonald appointed to AccuStem board effective Nov. 14, 2022; board expanded from four to five members.
- McDonald currently CEO of Ocugenix, a therapeutics company focusing on ocular diseases.
- He previously scaled Automated Healthcare (acquired by McKesson) and served as CEO of Precision Therapeutics.
- McDonald was a director at Respironics before its $5.1B acquisition by Philips.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850767/000149315222032628/0001493152-22-032628-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850767/000149315222032628/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-032628

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer